3-(3-Fluoro-phenyl)-3-oxo-propionic acid ethylester, 97.0%, 25g

(2-Bromophenyl)(pyrrolidin-1-yl)methanone, 95.0%, 100mg

2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione, 95.0%, 25mg

5-Iodopyrimidine-4,6-diamine, 95.0%, 100mg

1-Methyl-3-n-octylimidazolium Bromide, >98.0%(HPLC), 500g

2,6-Bis[(4R,5R)-4,5-dihydro-1-[(4-methylphenyl)sulfonyl]-4,5-diphenyl-1H-imidazol-2-yl]pyridine, 97%, 100mg

Methyl 2-(piperidin-4-yl)thiazole-4-carboxylate, 98%, 100mg

(S)-(2-Aminomethyl)-1-N-Boc-pyrrolidine, 97.0%, 10g

2-Bromo-1-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-one, 95.0%, 250mg

Acétate de zinc dihydraté, min 99 %, pa, ACS, 500 g, emballage plastique.

1-(1-ethoxyethyl)-4-iodo-1H-pyrazole, 95.0%, 5g

GalNAc beta(1-4)GlcNAc-beta-pNP>98.0%(HPLC)2mg

5-Methyl-1-phenylpyrazole-3-carboxylic acid, 95.0%, 10g